40 participants
Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-11-05
- Start Date:
- 2024-05-08
- Completion:
- 2025-12-01
Conditions
- Cervical Cancer
- Neoadjuvant Chemoimmunotherapy
- Fertility Preservation
Interventions
- DRUG
- PROCEDURE
No Results Yet